Exane Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-42,790
Closed -$3.42M 39
2019
Q2
$3.42M Buy
42,790
+11,591
+37% +$888K 1.52% 22
2019
Q1
$2.48M Buy
+31,199
New +$2.33M 1.2% 28
2017
Q4
Sell
-164,398
Closed -$10M 133
2017
Q3
$10M Buy
+164,398
New +$9.97M 1.96% 19
2017
Q1
Sell
-202,698
Closed -$11.4M 41
2016
Q4
$11.4M Sell
202,698
-112,444
-36% -$6.58M 3.75% 14
2016
Q3
$18.8M Buy
+315,142
New +$18.4M 5.88% 3

Other funds holding MRK

Exane Asset Management's MRK Position: Q3 2019 in Review

Exane Asset Management sold out of Merck (MRK) in Q3 2019, closing a stake of 42,790 shares — an estimated $3.42M sold.

Exane Asset Management first reported a position in MRK in Q3 2016 and held it in 5 quarters. The position peaked at $18.8M in Q3 2016. 2,305 funds tracked by Wall St. Rank hold MRK as of Q3 2019.

  • Exane Asset Management reported no remaining Merck position as of Q3 2019 after selling out during the quarter.
  • Exane Asset Management sold 42,790 Merck shares in Q3 2019, an estimated $3.42M.
  • Exane Asset Management first reported a position in Merck in Q3 2016 and held it in 5 quarters.
  • Exane Asset Management's Merck position peaked at $18.8M in Q3 2016.
  • 2,305 funds tracked by Wall St. Rank held Merck as of Q3 2019.

Based on Exane Asset Management's 13F filing for Q3 2019, filed 24 Oct 2019.